Hier finden Sie verschiedene Publikationen, die auf SCQM Daten basieren.
Jahr | Titel | Autoren | Journal | Laienzusammenfassung |
---|---|---|---|---|
2024 | Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registry |
Vallejo-Yagüe, Burkard, Finckh et al. | Journal: BMJ Open | |
2024 | Comparative Treatment Effectiveness In Rheumatoid Arthritis With And Without Concomitant Sjögren’s Disease - Results From The Swiss Clinical Quality Management Cohort |
Christ, Kissling, Kollert et. al. | Journal: Arthritis Research & Therapy | |
2024 | Anti-Apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox in rheumatoid arthritis |
Mongin, Pagano & Vuilleumier et al. | Journal: Frontiers in Cardiovascular Medicine | |
2024 | Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: results from the EuroSpA Research Collaboration Network. |
Hellamand, van de Sande, van der Horst-Bruinsma et al. | Journal: RMD Open | |
2024 | Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice |
Christiansen, Rasmussen, Ørnbjerg et al. | Journal: Seminars in Arthritis and Rheumatism | |
2024 | Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network |
Hellamand, van de Sande, van der Horst-Bruinsma et al. | Journal: Arthritis & Rheumatology | |
2024 | Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care |
Ørnbjerg, Rugbjerg, Østergaard et al. | Journal: The Journal of Rheumatology | Laienzusammenfassungen: PDF |
2024 | Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatment |
Ørnbjerg, Brahe, Hetland et al. | Journal: Joint Bone Spine | |
2024 | Enthesitis in a European registry-based cohort of patients with psoriaticarthritis treated with tumour necrosis factor inhibitors: clinical burden,patient-reported outcomes, and treatment response |
Mathew, Lund, Østergaard et al. | Journal: Scandinavian Journal of Rheumatology | Laienzusammenfassungen: PDF |
2024 | Explainable deep learning for disease activity prediction in chronic inflammatory joint diseases |
Trottet, Allam & Ospelt et al. | Journal: PLOS Digital Health | Laienzusammenfassungen: PDF |
2024 | Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study |
Christiansen, Rasmussen, Ørnbjerg et al. | Journal: RMD Open | |
2024 | Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries |
Linde, Georgiadis, Østergaard et al. | Journal: American College of Rheumatology | |
2024 | Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable? |
Georgiadis, Midtbøll Ørnbjerg, Hetland et al. | Journal: The Journal of Rheumatology | |
2023 | Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry |
Ciurea, Götschi & Micheroli et al. | Journal: RMD Open | |
2023 | Site-specific assessment of spinal radiographic progression improves detection of TNF blocker-associated disease modification in axial spondyloarthritis: Longitudinal observational data from the Swiss Clinical Quality Management Registry |
Popova, Kissling & Ciurea et al. | Journal: Arthritis Research & Therapy | |
2023 | Anaemia is associated with higher disease activity in axial spondyloarthritis, but is not an independent predictor of spinal radiographic progression: Data from the Swiss Clinical Quality Management Registry |
Micheroli, Kissling & Ciurea et al. | Journal: Clinical Rheumatology | |
2023 | One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment |
Ørnbjerg, Rugbjerg & Hetland et al. | Journal: The Journal of Rheumatology | |
2023 | Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries |
Dominique, Lund Hetland, Simon et al. | Journal: Arthritis Research & Therapy | |
2023 | Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs |
Kalweit, Burden & Burkard et al. | Journal: PLOS computational Biology | |
2023 | Impact of sex on spinal radiographic progression in axial spondyloarthritis: a longitudinal Swiss cohort analysis over a period of 10 years |
Ensslin, Micheroli & Ciurea et al. | Journal: RMD Open | |
2023 | Obesity represents an increasing health issue in axial spondyloarthritis, particularly affecting socially disadvantaged patients |
Micheroli, Bhatia & Ciurea et al. | Journal: The Journal of Rheumatology | Laienzusammenfassungen: Editor's Picks Spotlight (in EN) |
2023 | Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care |
Riek, Scherer & Finckh et al. | Journal: Scientific Reports | Laienzusammenfassungen: PDF |
2023 | Longitudinal associations between body mass index and changes indisease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab |
Theresa Burkard, Enriqueta Vallejo-Yagüe et al. | Journal: RMD Open | Laienzusammenfassungen: PDF |
2023 | Impact of SARS-CoV2 infection on anti-Apolipoprotein A-1 IgG response in inflammatory rheumatic diseases. |
Lamacchia, Mongin & Vuilleumier et al. | Journal: Frontiers in Immunology | |
2023 | Characterization of serum biomarkers and antibody responses against Prevotella spp. in preclinical and new-onset phase of rheumatic diseases |
Amend, Gilbert & Strowig et al. | Journal: Frontiers in Cellular and Infection Microbiology | |
2023 | Biological disease-modifying anti-rheumatic drugs are equally effective in psoriatic arthritis patients with low and high joint counts |
Möller, Scholz & Yawalkar et al. | Journal: Rheumatology | Laienzusammenfassungen: PDF |
2023 | Differences and similarities between the latest EULAR/ASAS-EULAR recommendations and national guidelines for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe |
Michelsen, Østergaard & Lund Hetland et al. | Journal: The Lancet | |
2023 | Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries |
Linde, Ørnbjerg & Østergaard et al. | Journal: Rheumatology | |
2023 | “Early” axial spondyloarthritis according to the 2023 ASAS consensus definition: characterization of patients and retention of a first TNF inhibitor in a large observational registry |
Ciurea, Götschi & Micheroli et al. | Journal: RMD Open | |
2023 | Evaluation and comparison of oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: results from the international TOCERRA and PANABA observational collaborative studies |
Lauper, Mongin & Gabay et al. | Journal: Joint Bone Spine | |
2023 | Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study) |
Aymon, Mongin & Lauper et al. | Journal: Annals of the Rheumatic Diseases | |
2023 | A potential role for chlamydial infection in rheumatoid arthritis development |
Lamacchia, Aymon & Finckh et al. | Journal: Rheumatology | |
2023 | Second and third TNF inhibitors in European patients with axial spondyloarthritis: Effectiveness and impact of reason for withdrawal from the previous treatment |
Linde, Ørnbjerg, Brahe et al. | Journal: Rheumatology | |
2023 | Commonalities and differences in set-up and data collection across European spondyloarthritis registries |
Linde, Ørnbjerg, Rasmussen | Journal: Arthritis Research & Therapy | |
2023 | Detection and Grading of Radiographic Hand Osteoarthritis Using an Automated Machine Learning Platform |
Caratsch, Lechtenboehmer, Hügle et al. | Journal: ACR Open Rheumatology | |
2022 | Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in the Swiss Clinical Quality Management cohort |
Vallejo-Yagüe, Burkard & Burden et al. | Journal: medRxiv | |
2022 | Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort |
Ciurea, Kissling & Micheroli et al. | Journal: RMD Open | |
2022 | Sacroiliac joint radiographic progression in axial spondyloarthritis is retarded by the therapeutic use of TNF inhibitors: 12- year data from the SCQM registry |
Micheroli, Kissling & Ciurea et al. | Journal: RMD Open | Laienzusammenfassungen: bechterew.ch |
2022 | Does tenosynovitis of the hand detected by B-mode ultrasound predict loss of clinical remission in rheumatoid arthritis? Results from a real-life cohort. |
Micheroli, Scherer & Tamborrini et al. | Journal: Journal of Ultrasonography | |
2022 | The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis |
Nissen, Delcoigne & Lindström et al. | Journal: Rheumatology | |
2022 | Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy |
Amstad, Papagiannoulis & Kyburz et al. | Journal: Rheumatology | |
2022 | Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort |
Vallejo-Yagüe, Burkard & Burden et al. | Journal: BMJ Open | |
2022 | Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration |
Lauper, Iudici & Finckh et al. | Journal: Annals of the Rheumatic Diseases | |
2022 | Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration |
Ørnbjerg, Linde & Hetland et al. | Journal: Seminars in Arthritis and Rheumatism | |
2022 | Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland |
Burkard, Vallejo-Yagüe & Burden et al. | Journal: BMJ Open | Laienzusammenfassungen: PDF |
2022 | Collaborative challenges of multi-cohort project in pharmacogenetics - why time is essential for meaningful collaborations |
Franchini, Kusejko & Leichtle et al. | Journal: JMIR Formative Research | |
2022 | Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases |
Raptis, Berger & Rubbert-Roth et al. | Journal: Frontiers in Immunology | Laienzusammenfassungen: PDF |
2022 | Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP) |
Meissner, Strangfeld & Fischer-Betz | Journal: Annals of the Rheumatic Diseases | |
2022 | Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort |
Enriqueta Vallejo-Yagüe ,Theresa Burkard et al. | Journal: PLOS ONE | |
2022 | Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling |
Soomro, Stadler, Barton et. al. | Journal: Arthritis & Rheumatology | |
2022 | Combining individual patient data from randomized and non-randomized studies to predict real-world effectiveness of interventions |
Seo, Debray, Ruffieux et al. | Journal: Statistical Methods in Medical Research | Laienzusammenfassungen: PDF |
2021 | Analysis of patients with rheumatoid arthritis and higher radiographic progression: association of very high radiographic progression but not of intermediately high with worsening of patient-related outcomes |
Thalmann, Von Kempis & Mueller et al. | Journal: Clinical and Experimental Rheumatology | |
2021 | Discontinuation of biologic DMARDs in a real-world population of patients with rheumatoid arthritis in remission: outcome and risk factors |
Arnold, Jaeger & Kyburz et al. | Journal: Rheumatology | |
2021 | Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis |
Lechtenboehmer, Burkard & Hügle et al. | Journal: Arthritis Research & Therapy | |
2021 | Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritis |
Lamacchia, Courvoisier & Nissen et al. | Journal: Rheumatology | |
2021 | Impact of assessing patient-reported outcomes with mobile apps on patient-provider interaction |
Shaw, Courvoisier & Finckh et al. | Journal: RMD Open | |
2021 | European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response |
Christiansen, Ørnbjerg & Hetland et al. | Journal: Rheumatology | |
2021 | Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration |
Lindström, Di Giuseppe & Nissen et al. | Journal: Annals of the Rheumatic Diseases | |
2021 | Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors |
Nissen, Möller & Hügle et al. | Journal: Arthritis Research & Therapy | Laienzusammenfassungen: PDF |
2021 | Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural network |
Kalweit, Walker & Hügle et al. | Journal: PLOS ONE | |
2021 | Real-world 6 and 12-month Drug Retention, Remission and Response Rates of Secukinumab in 2,017 Psoriatic Arthritis patients in 13 European Countries |
Michelsen, Georgiadis & Hetland et al. | Journal: Arthritis Care & Research | |
2021 | Comparison of Psoriatic Arthritis and Rheumatoid Arthritis Patients across Body Mass Index Categories in Switzerland |
Vallejo-Yagüe, Burkard & Burden et al. | Journal: Journal of Clinical Medicine | Laienzusammenfassungen: PDF |
2021 | Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab |
Taleng, Lauper & Finckh et al. | Journal: RMD Open | |
2021 | Prediction of sustained biologic and targeted synthetic DMARD free remission in rheumatoid arthritis patients |
Burkard, Williams & Burden et al. | Journal: Rheumatology Advances in Practice | Laienzusammenfassungen: PDF |
2020 | The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries |
Courvoisier, Chatzidionysiou & Finckh et al. | Journal: Rheumatology | |
2020 | Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland. |
Finckh, Tellenbach & Zufferey et al. | Journal: RMD Open | |
2020 | Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort |
Hebeisen, Micheroli & Ciurea et al. | Journal: PLOS ONE | |
2020 | Personalized Prediction of Disease Activity in Patients with Rheumatoid Arthritis Using an Adaptive Deep Neural Network |
Kalweit, Walker & Hügle et al. | Journal: PLOS ONE | |
2020 | Serum calprotectin: A promising biomarker in rheumatoid arthritis and axial spondyloarthritis |
Jarlborg, Courvoisier & Nissen et al. | Journal: Arthritis Research & Therapy | |
2020 | Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease |
Lamacchia, Sollet & Finckh et al. | Journal: Rheumatology | |
2020 | Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis |
Michelsen, Ørnbjerg & Østergaard et al. | Journal: Rheumatology | |
2020 | Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort |
Micheroli, Tellenbach & Ciurea et al. | Journal: Annals of the Rheumatic Diseases | |
2020 | Differences between men and women with nonradiographic axial spondyloarthritis: Clinical characteristics and treatment effectiveness in a real-life prospective cohort |
Neuenschwander, Hebeisen & Ciurea et al. | Journal: Arthritis Research & Therapy | |
2020 | Tumour Necrosis Factor Inhibitor monotherapy versus combination therapy for the treatment of psoriatic arthritis: combined analysis of European biologics databases |
Thomas, Shaddick & Nightingale et al. | Journal: The Journal of Rheumatology | |
2020 | Discordances between clinical and ultrasound measurements of disease activity among RA patients followed in real life |
Zufferey, Courvoisier & Finckh et al. | Journal: Joint Bone Spine | |
2020 | A Dynamic Deep Neural Network For Multimodal Clinical Data Analysis |
Hügle, Kalweit & Boedecker et al. | Journal: Springer, Cham | |
2020 | Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration |
Michelsen, Lindström & Østergaard et al. | Journal: RMD Open | |
2020 | Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases : results from the Swiss Clinical Quality Management cohort |
Ciurea, Papagiannoulis & Finckh et al. | Journal: Annals of the Rheumatic Diseases | |
2019 | Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts |
Boel, Molto & Ramiro et al. | Journal: Annals of the Rheumatic Diseases | |
2019 | Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment—results from 12 countries in EuroSpA |
Brahe, Ørnbjerg & Hetland et al. | Journal: Rheumatology | |
2019 | Role of reproductive and menopausal factors in functional and structural progression of rheumatoid arthritis: Results from the SCQM cohort |
Alpizar-Rodriguez, Förger & Finckh et al. | Journal: Rheumatology | |
2019 | Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution |
Lauper, Mongin & courvoisier et al. | Journal: Rheumatology | |
2019 | European Network of Pregnancy Registers in Rheumatology (EuNeP)- A n overview of procedures and data collection |
Meissner, Strangfeld & Fischer-Betz | Journal: Arthritis Research & Therapy | |
2019 | Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years |
Möller, Aletaha & Zufferey et al. | Journal: Rheumatology | |
2019 | Treatment response and drug retention rates in 24 195 biologic-naive patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration |
Ørnbjerg, Brahe & Østergaard et al. | Journal: Annals of the Rheumatic Diseases | |
2019 | Towards standardized patient reported physical function outcome reporting: linking ten commonly used questionnaires to a common metric |
Voshaar, Vonkeman & van de Laar et al. | Journal: Quality of Life Research | |
2019 | Bone erosion scoring for rheumatoid arthritis with deep convolutional neural networks |
Rohrbach, Reinhard & Dürr et al. | Journal: Computers & Electrical Engineering | |
2019 | The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis |
Scholz, Leichtle & Möller et al. | Journal: British Journal of Haematology | |
2019 | Brief report: Influence of Disease Activity in Rheumatoid Arthritis on Radiographic Progression of Concomitant Interphalangeal Joint Osteoarthritis |
Lechtenboehmer, Jaeger & Hügle et al. | Journal: Arthritis & Rheumatology | |
2019 | Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab inpatients with axial spondyloarthritis |
Hebeisen, Scherer & Ciurea et al. | Journal: PLOS ONE | |
2018 | Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis |
Didden, Ruffieux & Egger et al. | Journal: Medical Decision Making | |
2018 | Response to tumor necrosis factor inhibition in male and female patients with ankylosing spondylitis: Data from a Swiss Cohort |
Hebeisen, Neuenschwander & Ciurea et al. | Journal: The Journal of Rheumatology | |
2018 | Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort |
Heinimann, Von Kempis & Müller et al. | Journal: Journal of Clinical Medicine | |
2018 | Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis |
Lauper, Courvoisier & Gabay et al. | Journal: Arthritis Care & Research | |
2018 | Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration |
Lauper, Nordström & Gabay et al. | Journal: Annals of the Rheumatic Diseases | |
2018 | Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries |
Lauper, Mongin & Gabay et al. | Journal: RMD Open | |
2018 | Comparison of serological biomarkers in rheumatoid arthritis and their combination to improve diagnostic performance |
Martinez-Prat, Nissen & Mahler et al. | Journal: Frontiers in Immunology | |
2018 | TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: Results from the Swiss Clinical Quality Management cohort |
Molnar, Scherer & Ciurea et al. | Journal: Annals of the Rheumatic Diseases | |
2018 | Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: Results from the swiss prospective observational cohort |
Mueller, Kaegi & von Kempis et al. | Journal: RMD Open | |
2018 | Can ultrasound be used to predict loss of remission in patients with RA in a real-life setting? A multicenter cohort study |
Zufferey, Scherer & Ziswiler et al. | Journal: The Journal of Rheumatology | |
2017 | Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life |
Chaigne, Finckh & Chizzolini et al. | Journal: Quality of Life Research | |
2017 | Rituximab retreatment in rheumatoid arthritis in a real-life cohort: Data from the CERERRA collaboration |
Chatzidionysiou, Lie & van Vollenhoven et al. | Journal: The Journal of Rheumatology | |
2017 | Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA) |
Iannone, Courvoisier & Finckh et al. | Journal: Clinical Rheumatology | |
2017 | Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics : results from a collaborative project of 11 European biologic registers |
Mercer, Askling & Listing et al. | Journal: Annals of the Rheumatic Diseases | |
2017 | Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis |
Micheroili, Hebeisen & Ciurea et al. | Journal: Arthritis Research & Therapy | |
2017 | Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM) |
Mueller, Reshiti & von Kempis et al. | Journal: Clinical Rheumatology | |
2017 | Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtyping |
Stekhoven, Scherer & Möller et al. | Journal: Clinical Rheumatology | |
2016 | Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: Data from the CERERRA collaboration |
Chatzidionysiou, Lie & van Vollenhoven et al. | Journal: Arthritis Research & Therapy | |
2016 | Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis Results from the Swiss Clinical Quality Management Cohort |
Ciurea, Exer & Scherer et al. | Journal: Arthritis Research & Therapy | |
2016 | Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis |
Ciurea, Scherer & Finckh et al. | Journal: Annals of the Rheumatic Diseases | |
2016 | Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study |
Courvoisier, Alpizar-Rodriguez & Finckh et al. | Journal: eBioMedicine | |
2016 | Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: Results from a European collaborative study |
Gabay, Riek & Kvien et al. | Journal: Annals of the Rheumatic Diseases | |
2016 | Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity with Better Effectiveness of Abatacept: Results from the Pan-European Registry Analysis |
Gottenberg, Courvoisier & Finckh et al. | Journal: Arthritis & Rheumatology | |
2016 | The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis |
Nissen, Ciurea & Finckh et al. | Journal: Arthritis & Rheumatology | |
2015 | Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis: Comparison between private rheumatology practices and academic centers in a large observational cohort |
Ciurea, Weber & Exer et al. | Journal: The Journal of Rheumatology | |
2015 | Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: Data from the Swiss Clinical Quality Management Registry |
Gabay, Riek & Finckh et al. | Journal: Rheumatology | |
2015 | Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study |
Möller, Pruijm & Finckh et al. | Journal: Annals of the Rheumatic Diseases | |
2015 | The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis |
Mueller, Schiff & von Kempis et al. | Journal: Clinical Rheumatology | |
2015 | Rituximab done: What's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis |
Walker, Jaeger & Gabay et al. | Journal: Rheumatology | |
2015 | The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries |
Finckh, Neto & Turesson et al. | Journal: RMD Open | |
2014 | Joint damage progression in patients with rheumatoid arthritis in clinical remission. Do biologics perform better than synthetic antirheumatic drugs? |
Ciubotariu, Gabay & Finckh | Journal: The Journal of Rheumatology | |
2014 | Age at symptom onset in ankylosing spondylitis: Is there a gender difference? |
Ciurea, Scherer & Stekhoven et al. | Journal: Annals of the Rheumatic Diseases | |
2014 | Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: A prospective cohort study |
Möller, Scherer & Finckh et al. | Journal: Annals of the Rheumatic Diseases | |
2014 | Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis |
Mueller, Kaegi & von Kempis et al. | Journal: Rheumatology | |
2014 | Ultrasound evaluation of synovitis in RA: Correlation with clinical disease activity and sensitivity to change in an observational cohort study |
Zufferey, Brulhart & Ziswiler et al. | Journal: Joint Bone Spine | |
2014 | Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: Results of an observational cohort study |
Zufferey, Möller & Ziswiler et al. | Journal: Joint Bone Spine | |
2013 | Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: Results from a large observational cohort |
Ciurea, Scherer & Weber et al. | Journal: Arthritis & Rheumatism | |
2013 | Smoking and spondyloarthritis |
Ciurea & Finckh | Journal: Joint Bone Spine | |
2013 | Recommendations for the use of ultrasound in rheumatoid arthritis: Literature review and SONAR score experience |
Zufferey, Tamborrini & Ziswiler et al. | Journal: Swiss Medical Weekly | |
2013 | Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: Results from the Swiss SCQM registry |
Zufferey, Dudler & Finckh et al. | Journal: Joint Bone Spine | |
2012 | Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: Results of a 1-year follow-up study from the CERERRA collaboration |
Chatzidionysiou, Lie & Gabay et al. | Journal: Annals of the Rheumatic Diseases | |
2012 | Pain as an important predictor of psychosocial health in patients with rheumatoid arthritis |
Courvoisier, Agoritsas & Finckh et al. | Journal: Arthritis Care & Research | |
2012 | Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients |
Martin Du Pan, Scherer & Finckh et al. | Journal: Annals of the Rheumatic Diseases | |
2012 | Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists |
Finckh, Möller & Gabay et al. | Journal: Annals of the Rheumatic Diseases | |
2011 | Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: Pooled data from 10 European registries |
Chatzidionysiou, Lie & Vollenhoven et al. | Journal: Annals of the Rheumatic Diseases | |
2011 | The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study. |
Kyburz, Gabay & Finckh et al. | Journal: Rheumatology | |
2011 | Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion |
Walker, Courvoisier & Scherer et al. | Journal: Rheumatology | |
2010 | A Comparison of Patient Characteristics and Outcomes in Selected European and U.S. Rheumatoid Arthritis Registries |
Curtis, Jain & Zink et al. | Journal: Seminars in Arthritis and Rheumatism | |
2010 | Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? |
Finckh, Ciurea & Gabay et al. | Journal: Annals of the Rheumatic Diseases | |
2010 | Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients |
Finckh, Dudler & Bas et al. | Journal: Joint Bone Spine | |
2010 | The effect of alcohol on radiographic progression in rheumatoid arthritis |
Nissen, Gabay & Finckh et al. | Journal: Arthritis & Rheumatism | |
2009 | The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: A population-based study |
Finckh, Dehler & Gabay et al. | Journal: Annals of the Rheumatic Diseases | |
2009 | Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis |
Martin Du Pan, Dehler & Finckh et al. | Journal: Arthritis Care & Research | |
2007 | Cigarette smoking and radiographic progression in rheumatoid arthritis |
Finckh, Dehler & Gabay et al. | Journal: Annals of the Rheumatic Diseases | |
2007 | B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents |
Finckh, Ciurea & Gabay et al. | Journal: Arthritis & Rheumatism | |
2007 | Tolerance and effectiveness of anti-tumor necrosis factor α therapies in elderly patients with rheumatoid arthritis: A population-based cohort study |
Genevay, Finckh & Gabay et al. | Journal: Arthritis Care & Research | |
2006 | Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis |
Finckh, Simard & Guerne et al. | Journal: Annals of the Rheumatic Diseases | |
2006 | The effectiveness of anti-tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: A population-based study |
Finckh, Simard & Guerne et al. | Journal: Arthritis & Rheumatism | |
2006 | Clinical evaluation of a cohort of patients with rheumatoid arthritis treated with anti-TNF-alpha in the community |
Genta, Kardes & Gabay | Journal: Joint Bone Spine | |
2000 | Clinical quality management in rheumatoid arthritis: Putting theory into practice |
Uitz, Fransen & Stucki et al. | Journal: Rheumatology |